| Sep 26 |
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Sep 23 |
Catherine Owen appointed as CEO of Acadia Pharmaceuticals
|
| Sep 23 |
Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals
|
| Sep 3 |
High Growth Tech Stocks To Watch In September 2024
|
| Aug 29 |
Implied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options
|
| Aug 27 |
Jim Cramer Believes In Dell CEO, Doesn't Like B&G Foods
|
| Aug 26 |
Acadia Pharmaceuticals: Nuplazid Performs In Q2 While Daybue Disappoints Again
|
| Aug 14 |
Ryan Reynolds Announces More to Parkinson’s® Campaign
|
| Aug 14 |
Shareholders Can Be Confident That ACADIA Pharmaceuticals' (NASDAQ:ACAD) Earnings Are High Quality
|
| Aug 8 |
ACADIA Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations
|
